CME Quiz

Please print this page to complete and return the quiz and forms to:
CME Consultants, Inc., 94 Main St. Wakefield, RI 02879,
or fax to (401) 789-1009 baixar iq option

1 .The echinocandins demonstrate in vitro antifungal activity against:

a) Candida spp.
b) Aspergillus spp.
c) Pneumocystis carinii
d) all of the above
e) none of the above

2. Empiric antifungal therapy is the initiation of antifungal therapy in patients with persistent fever and neutropenia despite the use of broad-spectrum antibiotics only after cultures are positive for a pathogenic yeast or mould.
True or false?

a) True
b) False

3. Caspofungin plus L-AmB or caspofungin plus voriconazole have been shown to be useful salvage therapy for invasive aspergillosis refractory to amphotericin B. However:

a) Combination therapy is still experimental
b) The small population sizes make these studies difficult to interpret clinically
c) Large, well designed studies are needed to determine their value in invasive fungal infection
d) Clinical studies are needed to gain further experience of this approach to treatment
e) All of the above

4. Lipid formulations of amphotericin B have been developed in an effort to reduce the dose-limiting toxicity of this drug.
True or false?

a) True
b) False

5. Risk factors for invasive fungal infections include:

a) Immunosuppressive therapy
b) Neutropenia
c) Recent major surgery
d) All of the above
e) None of the above

6. In most surveys Candida albicans is the species isolated in virtually all cases of nosocomial candidemia.
True or False?

a) True
b) False

7. Invasive aspergillosis is typically acquired following:

a) the use of catheters
b) solid organ transplant
c) inhalation of airborne spores
d) exposure to broad-spectrum antimicrobial agents

8. A recent CDC survey showed declining mortality due to Candida. This decrease was suggested to be due to better recognition of these infections and earlier initiation of antifungal therapy.
True or false?

a) True
b) False



Evaluation Form
Date of original release: August 2004
Valid for CME credit through August 2005

Learning Objectives

At the conclusion of this activity, the participant should be able to:
  • Review the epidemiology of fungal infections in immunosuppressed patients
  • Compare the different treatment approaches to fungal infections
  • Discuss the clinical indications for each treatment approach
  • Analyze the latest clinical data on therapeutic options
  • Evaluate the optimal treatment strategy for their individual patients
Please indicate your evaluation of the effectiveness of this CME activity on a scale of 1–5, with 5 being the highest, by circling your choice.

Please comment on the impact (if any) that this CME activity might have on your management of patients.

Additional comments and/or suggested topics for future CME activities.

Do you feel the activity was objective, balanced and free of commercial bias?


Would a periodic review of this or related material be appropriate?


May we contact you 3 months after this activity to
evaluate change in patient care?

If yes, please supply your e-mail address or fax number, which will remain confidential.


Registration Form for CME Accreditation

Please complete the Evaluation and Registration forms and return to:
CME Consultants, Inc.,
94 Main St, Wakefield, RI 02879
or fax to (401) 789-1009. Please read the instructions below.

This activity is designated for 1 (one) AMA PRA category 1 credit. In order to receive your CME credit you are requested to review the material in full and answer the quiz. (The correct answer to each question is provided at the end of the quiz for you to mark your responses.) Once you have completed the quiz, please note in the space provided on the registration form, your total score and the amount of time it took you to complete the entire activity, including the quiz and evaluation.

Please indicate your total score from the CME quiz.


Approximately how many minutes did it take you to complete      
this CME activity, including the quiz and evaluation?


Date of original release: August 2004
Valid for CME credit through August 2005
Please return by August 2005 in order to receive your CME credits.